MarineMax, Inc. (HZO) Reaches $24.15 52-Week High; Goldman Sachs Group Lowered Hca Healthcare (Put) (HCA) Holding

May 16, 2018 - By Kurt Siggers

MarineMax, Inc. (NYSE:HZO) Logo

The stock of MarineMax, Inc. (NYSE:HZO) hit a new 52-week high and has $25.84 target or 7.00% above today’s $24.15 share price. The 7 months bullish chart indicates low risk for the $536.85 million company. The 1-year high was reported on May, 16 by Barchart.com. If the $25.84 price target is reached, the company will be worth $37.58M more. The stock increased 1.47% or $0.35 during the last trading session, reaching $24.15. About 33,005 shares traded. MarineMax, Inc. (NYSE:HZO) has declined 11.01% since May 16, 2017 and is downtrending. It has underperformed by 22.56% the S&P500.




Goldman Sachs Group Inc decreased Hca Healthcare Inc (Put) (HCA) stake by 71.31% reported in 2017Q4 SEC filing. Goldman Sachs Group Inc sold 115,100 shares as Hca Healthcare Inc (Put) (HCA)’s stock rose 9.36%. The Goldman Sachs Group Inc holds 46,300 shares with $4.07M value, down from 161,400 last quarter. Hca Healthcare Inc (Put) now has $35.62B valuation. The stock increased 0.89% or $0.9 during the last trading session, reaching $101.96. About 236,763 shares traded. HCA Healthcare, Inc. (NYSE:HCA) has risen 7.67% since May 16, 2017 and is uptrending. It has underperformed by 3.88% the S&P500.

MarineMax, Inc. operates as a recreational boat retailer in the United States. The company has market cap of $536.85 million. It sells new and used recreational boats, including pleasure boats, such as sport boats, sport cruisers, sport yachts, and other yachts; fishing boats; convertible yachts; motor yachts; ski boats; and jet boats. It has a 23.29 P/E ratio. The firm also offers marine parts and accessories that comprise marine electronics; dock and anchoring products consisting of boat fenders, lines, and anchors; boat covers; trailer parts; water sport accessories, such as tubes, lines, wakeboards, and skis; engine parts; oils; lubricants; steering and control systems; corrosion control products; service products; accessories, including propellers and instruments; and a line of boating accessories comprising life jackets, inflatables, and water sports equipment.

Investors sentiment decreased to 0.78 in Q4 2017. Its down 0.34, from 1.12 in 2017Q3. It dropped, as 10 investors sold MarineMax, Inc. shares while 50 reduced holdings. 27 funds opened positions while 20 raised stakes. 21.65 million shares or 6.13% less from 23.06 million shares in 2017Q3 were reported. Foundry Prns Limited Liability has 0.11% invested in MarineMax, Inc. (NYSE:HZO) for 134,215 shares. Ameriprise Fin accumulated 114,113 shares or 0% of the stock. Northern Trust reported 285,026 shares or 0% of all its holdings. Rice Hall James Assocs Limited Com has 0.08% invested in MarineMax, Inc. (NYSE:HZO). Bancorporation Of Mellon invested in 0% or 276,241 shares. Sector Pension Investment Board reported 0% of its portfolio in MarineMax, Inc. (NYSE:HZO). Parallax Volatility Advisers L P reported 3,444 shares stake. Pnc Financial Svcs Gru Inc Inc stated it has 3,653 shares. 154,229 are owned by D E Shaw Company Inc. Royal National Bank & Trust Of Canada reported 0% in MarineMax, Inc. (NYSE:HZO). 40,511 were accumulated by Legal General Grp Public Limited Liability Corporation. Parkside Fin Bank Trust accumulated 25 shares. 39,438 are owned by Raymond James And Assocs. Millennium Lc holds 0% of its portfolio in MarineMax, Inc. (NYSE:HZO) for 53,421 shares. Voya Investment Management Limited Liability stated it has 11,870 shares or 0% of all its holdings.

Analysts await MarineMax, Inc. (NYSE:HZO) to report earnings on July, 19. They expect $0.81 earnings per share, up 42.11% or $0.24 from last year’s $0.57 per share. HZO’s profit will be $18.01 million for 7.45 P/E if the $0.81 EPS becomes a reality. After $0.25 actual earnings per share reported by MarineMax, Inc. for the previous quarter, Wall Street now forecasts 224.00% EPS growth.

Among 11 analysts covering Marinemax (NYSE:HZO), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Marinemax has $29 highest and $19.75 lowest target. $25.08’s average target is 3.85% above currents $24.15 stock price. Marinemax had 24 analyst reports since July 24, 2015 according to SRatingsIntel. B. Riley & Co maintained MarineMax, Inc. (NYSE:HZO) rating on Thursday, October 26. B. Riley & Co has “Buy” rating and $19.75 target. As per Tuesday, October 31, the company rating was maintained by SunTrust. Northcoast maintained the shares of HZO in report on Wednesday, January 24 with “Buy” rating. On Thursday, April 26 the stock rating was maintained by Craig Hallum with “Buy”. The firm has “Buy” rating given on Thursday, December 3 by Craig Hallum. On Friday, February 10 the stock rating was initiated by Citigroup with “Buy”. As per Thursday, April 26, the company rating was maintained by FBR Capital. FBR Capital maintained the stock with “Buy” rating in Monday, January 22 report. As per Friday, April 27, the company rating was maintained by B. Riley & Co. CL King upgraded the shares of HZO in report on Thursday, January 25 to “Buy” rating.

Since January 24, 2018, it had 0 buys, and 8 insider sales for $3.91 million activity. 3,054 shares were sold by Day Paulee C, worth $73,479 on Friday, January 26. 50,000 shares were sold by MCLAMB MICHAEL H, worth $1.20M. EURE HILLIARD M had sold 10,000 shares worth $231,400. $343,250 worth of MarineMax, Inc. (NYSE:HZO) was sold by Cassella Anthony E. Jr. on Thursday, May 3. Cashman Charles A sold $573,049 worth of stock or 25,000 shares. $1.18M worth of MarineMax, Inc. (NYSE:HZO) shares were sold by MCGILL WILLIAM H JR.

More important recent MarineMax, Inc. (NYSE:HZO) news were published by: Seekingalpha.com which released: “MarineMax: Better Options Available” on April 30, 2018, also Seekingalpha.com published article titled: “Why Powerboat Sales Won’t Mean-Revert”, Benzinga.com published: “Earnings Preview For MarineMax” on April 25, 2018. More interesting news about MarineMax, Inc. (NYSE:HZO) was released by: Seekingalpha.com and their article: “MarineMax Inc. 2018 Q2 – Results – Earnings Call Slides” with publication date: April 27, 2018.

More notable recent HCA Healthcare, Inc. (NYSE:HCA) news were published by: Streetinsider.com which released: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018, also Bizjournals.com with their article: “TriStar announces more than $500 million in Middle Tennessee investments” published on May 14, 2018, Streetinsider.com published: “Appaloosa 13F Shows New Stake in Wells Fargo (WFC) and Lam Research (LRCX), Increase in Micron (MU) MGM …” on May 15, 2018. More interesting news about HCA Healthcare, Inc. (NYSE:HCA) were released by: Globenewswire.com and their article: “Factors of Influence in 2018, Key Indicators and Opportunity within HCA Healthcare, Apartment Investment and …” published on May 07, 2018 as well as Seekingalpha.com‘s news article titled: “Why I’m Long HCA Holdings” with publication date: April 28, 2018.

Among 30 analysts covering HCA Holdings (NYSE:HCA), 20 have Buy rating, 2 Sell and 8 Hold. Therefore 67% are positive. HCA Holdings had 102 analyst reports since August 6, 2015 according to SRatingsIntel. As per Thursday, October 19, the company rating was maintained by Robert W. Baird. The rating was maintained by KeyBanc Capital Markets on Wednesday, October 18 with “Buy”. The firm has “Mkt Outperform” rating by Avondale given on Tuesday, January 17. As per Tuesday, May 1, the company rating was maintained by Cantor Fitzgerald. The rating was downgraded by Leerink Swann on Wednesday, January 6 to “Mkt Perform”. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, October 28 report. The stock of HCA Healthcare, Inc. (NYSE:HCA) earned “Buy” rating by Mizuho on Friday, July 29. Oppenheimer maintained the shares of HCA in report on Tuesday, July 25 with “Buy” rating. The firm earned “Buy” rating on Thursday, October 19 by RBC Capital Markets. Robert W. Baird maintained the stock with “Buy” rating in Tuesday, January 30 report.

Investors sentiment decreased to 0.78 in 2017 Q4. Its down 0.01, from 0.79 in 2017Q3. It is negative, as 53 investors sold HCA shares while 199 reduced holdings. 75 funds opened positions while 121 raised stakes. 250.97 million shares or 4.23% less from 262.04 million shares in 2017Q3 were reported. Bluecrest Cap Management Limited has 0.04% invested in HCA Healthcare, Inc. (NYSE:HCA). Rbf Cap Limited Liability Company accumulated 75,000 shares or 0.73% of the stock. Prescott Gp Capital Management Ltd Liability reported 10,000 shares stake. Commerzbank Aktiengesellschaft Fi has invested 0.01% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA). Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0.12% or 157,995 shares. Brave Warrior Advsrs Lc reported 10.88% stake. Mitsubishi Ufj Trust & owns 582,733 shares or 0.09% of their US portfolio. The New York-based Glenview Cap Mngmt Limited Liability has invested 5.86% in HCA Healthcare, Inc. (NYSE:HCA). 45,912 were accumulated by Sg Americas Ltd Liability. Wellington Management Group Inc Llp reported 0.35% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA). Gradient Invs Limited Liability Company holds 9 shares or 0% of its portfolio. 7,400 were accumulated by Patten & Patten Tn. Diversified Communications holds 0.08% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA) for 15,357 shares. Bessemer Grp Inc has invested 0% in HCA Healthcare, Inc. (NYSE:HCA). Employees Retirement System Of Texas reported 0.07% in HCA Healthcare, Inc. (NYSE:HCA).

Analysts await HCA Healthcare, Inc. (NYSE:HCA) to report earnings on July, 24. They expect $2.15 earnings per share, up 22.86% or $0.40 from last year’s $1.75 per share. HCA’s profit will be $751.00 million for 11.86 P/E if the $2.15 EPS becomes a reality. After $2.33 actual earnings per share reported by HCA Healthcare, Inc. for the previous quarter, Wall Street now forecasts -7.73% negative EPS growth.

MarineMax, Inc. (NYSE:HZO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: